Search

Your search keyword '"Blasco, Miquel"' showing total 335 results

Search Constraints

Start Over You searched for: Author "Blasco, Miquel" Remove constraint Author: "Blasco, Miquel"
335 results on '"Blasco, Miquel"'

Search Results

51. Cloning and Identification System of <em>Apis mellifera</em> Melittin cDNA in <em>Escherichia coli</em>

52. Eculizumab in secondary atypical haemolytic uraemic syndrome

54. Risk Factors for Acute Kidney Injury Following Cardiac Surgery and Performance of Leicester Score in a Spanish Cohort

56. Cloudy fluid, cloudy diagnosis

57. The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics

59. Antiphospholipase A2 receptor antibody-positive membranous nephropathy in the kidney donor: Lessons from a serendipitous transplantation

64. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome

65. El impuesto sobre las transacciones financieras: a propósito de la nueva ley 5/2020, de 15 de octubre, del impuesto sobre las transacciones financieras, en España

66. TriviaRace : joc XNA per a Xbox 360

67. Corrigendum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2020;97:1287–1296

69. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

70. Use of tocilizumab in kidney transplant recipients with COVID-19

71. Management of acute renal replacement therapy in critically ill cirrhotic patients.

72. Saber, principios y deliberación. Una interpretación del saber moral en el «Critón» de Platón

73. Use of tocilizumab in kidney transplant recipients with COVID-1

74. Thrombotic microangiopathies assessment: mind the complement

81. P0664CKDSENS, A NOVEL HEALTHCARE PLATFORM FOR CHRONIC KIDNEY DISEASE

83. Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy

85. SARS-CoV-2 and influenza virus co-infection

86. Successful use of nonantigen‐specific immunoadsorption with antihumanIg‐columnsin kidney graft antibody‐mediated rejection

87. IgA Nephropathy Recurrence after Kidney Transplantation: Role of Recipient Age and Human Leukocyte Antigen-B Mismatch

89. Complement Activation and Thrombotic Microangiopathies

91. Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy.

92. Thrombotic microangiopathies assessment: mind the complement.

93. Severe acute kidney injury in critically ill COVID-19 patients.

99. Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome

Catalog

Books, media, physical & digital resources